GSK Plc (GSK)
50.79
+0.89
(+1.78%)
USD |
NYSE |
Jan 14, 16:00
50.74
-0.05
(-0.10%)
Pre-Market: 20:00
GSK Market Cap: 102.06B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 298.70B |
| Biodexa Pharmaceuticals Plc | 1.753M |
| AnaptysBio, Inc. | 1.392B |
| NuCana Plc | 13.86M |
| Mereo BioPharma Group Plc | 113.94M |
Market Cap Related Metrics
| PE Ratio | 14.49 |
| PS Ratio | 2.490 |
| PEG Ratio | 0.1131 |
| Price to Book Value | 4.695 |
| Price to Free Cash Flow | 18.55 |
| Price | 50.79 |
| Earnings Yield | 6.90% |
| PEGY Ratio | 0.1102 |
| Operating PE Ratio | 10.60 |
| Normalized PE Ratio | 12.81 |